Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Brisdelle Generic Name & Formulations
Legal Class
Rx
General Description
Paroxetine (as mesylate) 7.5mg; caps.
Pharmacological Class
SSRI.
How Supplied
Caps—30
Manufacturer
Generic Availability
YES
Brisdelle Indications
Indications
Moderate to severe vasomotor symptoms associated with menopause.
Limitations of Use
Not indicated for treatment of any psychiatric condition.
Brisdelle Dosage and Administration
Adult
7.5mg once daily at bedtime.
Children
Not established.
Brisdelle Contraindications
Contraindications
During or within 14 days of MAOIs. Concomitant linezolid or IV methylene blue. Concomitant pimozide, thioridazine (may cause QTc prolongation). Pregnancy (Cat.X).
Brisdelle Boxed Warnings
Boxed Warning
Suicidal thoughts and behaviors.
Brisdelle Warnings/Precautions
Warnings/Precautions
Increased risk of suicidal thinking and behavior in children and young adults when used to treat depressive or other psychiatric disorders; monitor all patients for clinical worsening or unusual changes; consider discontinuing if occurs. Monitor for serotonin syndrome; discontinue if occurs. Risk of hyponatremia. Volume-depleted. Screen for risk of bipolar disorder prior to initiating therapy; monitor for mania/hypomania. History of seizures or with conditions that lower the seizure threshold; evaluate and consider discontinuing if occurs. Discontinue if akathisia occurs. Angle-closure glaucoma. Elderly. Nursing mothers: not recommended.
Brisdelle Pharmacokinetics
See Literature
Brisdelle Interactions
Interactions
See Contraindications. Concomitant other paroxetine-containing products: not recommended. Do not start MAOIs until at least 2 weeks after discontinuing paroxetine. Increased risk of serotonin syndrome with other serotonergic drugs (eg, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Avoid concomitant tamoxifen. May affect, or be affected by, drugs metabolized by CYP2D6, including nortriptyline, amitriptyline, imipramine, desipramine, fluoxetine, phenothiazines, risperidone, atomoxetine, digoxin, Class 1C antiarrhythmics (eg, propafenone, flecainide, encainide), quinidine. May potentiate protein-bound drugs (eg, warfarin) and theophylline; monitor. Potentiated by cimetidine; monitor. Antagonized by phenobarbital, phenytoin, fosamprenavir/ritonavir; monitor. Increased risk of bleeding with NSAIDs, aspirin, warfarin, or others that affect coagulation. Risk of hyponatremia with diuretics.
Brisdelle Adverse Reactions
Adverse Reactions
Headache, fatigue, nausea/vomiting; abnormal bleeding, suicidal ideation, hyponatremia, akathisia, serotonin syndrome, mania/hypomania, potential for bone fracture, sexual dysfunction.
Brisdelle Clinical Trials
See Literature
Brisdelle Note
Not Applicable
Brisdelle Patient Counseling
See Literature
Images
